Board of Directors

Alexander Shneider

Alexander Shneider,
Ph.D.


Chairman Of The Board





Over 25 years of biotech and entrepreneurial experience. Currently Senior Research Fellow of molecular biology at University of Ariel, Israel; editorial board member for journals Aging and Cell Cycle, advisor at We Fund Health. The past achievements and activities include but are not limited to drug development from concept to market authorization, patents in all major jurisdictions, advisory role for successful exits, consulting for Fortune 100 companies, establishing and leading international R&D consortia, senior authorship in papers and books.

Michael Burns, МСЕЕ

Michael Burns, МСЕЕ


Independent Director





Michael Burns has more than 20 years of experience in technology start-ups and private equity. He also has been a Partner at Alara Capital, a core advisor at Gauss Ventures, a Managing Director at Guggenheim Partners, and a Managing Director at TL Ventures. He has deep operating experience and has been part of many successful companies where he has been a co-founder, seed investor or senior executive including Agere (Agere Systems), Ciclon Semiconductor (Texas Instruments), and Traffic.com (Nokia). Michael graduated UPenn (engineering), and Warton Business School (finance) as a Benjamin Franklin Scholar.

Andrey-Morozov

Andrew Morozov
Ph.D., MBA


Independent Director





Andrew Morozov has more than 25 years of experience. Senior management positions with Fuji-Keizai, IBM Watson, A.T. Kearney, Gartner. Co-founded several startup companies: Decision Drivers, Amhurst Capital, Tundrex. Investment management experience: TL Ventures, Amhurst Capital, Cisco Systems, VEB Innovations Venture Fund resulting in 12 successful exits including Aberdeen Group, Grid Dynamics, Intellon, Mobix Chip, Datadvance. Andrew obtained M.Sc. with magna cum laude and Ph.D. Moscow Institute of Physics and Technology, and an M.B.A from the Wharton School at UPenn. In 2012, Andrew managed a $1M seed investment in CureLab Oncology.